V-Card | Print | PDF | Email Page

David B. Alden
Partner

Contact

(T) +1.216.586.7121
(F) +1.216.579.0212

Education

  • University of Michigan (J.D. magna cum laude 1983; Order of the Coif); Oberlin College (B.A. with honors in Economics 1980; Phi Beta Kappa)

Bar Admissions

  • Ohio; Florida; U.S. Supreme Court; U.S. Courts of Appeals for the Second, Third, Fifth, Sixth, Seventh, Tenth, and Eleventh Circuits; U.S. District Courts for the Northern and Southern Districts of Ohio and Eastern and Western Districts of Arkansas

Dave Alden's practice focuses on product liability and, in particular, on actions involving pharmaceuticals, medical devices, tobacco, and consumer products. He also has substantial experience defending accounting malpractice, RICO, and securities actions. Dave has been involved in multiple trials and appeals in state and federal courts. He regularly counsels clients regarding privilege and work product issues, including Ohio's attorney-client privilege statute, which was amended in 2013 as first advocated in Dave's 2011 law review article.

For years, Dave has represented clients as national coordinating counsel, including R.J. Reynolds in smoking and health actions and Wyeth in actions involving prescription antidepressants. He recently represented Bayer in an arbitration in which Recoly challenged Bayer discontinuing development of a hemophilia product, and Recoly's claims were denied. Dave previously was in-house counsel at a major accounting firm.

Dave coauthored Drug and Device Product Liability Litigation Strategy (Oxford Univ. Press 2012); "Voluntary Client Testimony As A Privilege Waiver: Is Ohio's Law Caught In A Time Warp?," 59(1) Clev. St. L. Rev. 1 (2011); and "The Meaning Of The Parallel Requirements Exception Under Lohr and Riegel," 65(3) N.Y.U. Ann. Surv. Am. L. 545 (2010). Since 2011, he has coauthored the Ohio chapter of Product Liability Desk Reference: A Fifty-State Compendium (Wolters Kluwer 2017).

Dave's pro bono representations include Raymond Towler, who was exonerated based on new DNA testing after 29 years in prison, and Douglas Prade, who was excluded from male DNA found over the murderer's bite on the victim and seeks a new trial.


David Alden